Reaction
Granulomatous Liver Disease reporting signals
As of the last recalculation, Granulomatous Liver Disease appears in 695 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 79.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifampicin | 26 | 79.9 | 80.1 |
| Pyrazinamide | 21 | 69.0 | 69.2 |
| Isoniazid | 24 | 45.9 | 46.0 |
| Amphotericin B | 14 | 34.1 | 34.2 |
| Daspone | 8 | 24.9 | 24.9 |
| Dapsone Gel, 5% | 8 | 24.9 | 24.9 |
| Adalimumab-Fkjp | 35 | 23.8 | 23.8 |
| Adalimumab-Aaty | 35 | 23.3 | 23.3 |
| Dapsone | 8 | 22.7 | 22.7 |
| Adalimumab-Adaz | 35 | 20.9 | 20.9 |
| Amikacin | 11 | 19.6 | 19.6 |
| Efavirenz | 7 | 19.0 | 19.0 |
| Dabrafenib | 12 | 17.3 | 17.3 |
| Rifampin | 8 | 16.6 | 16.6 |
| Voriconazole | 16 | 16.1 | 16.1 |
| Trametinib | 12 | 15.1 | 15.1 |